Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Effectiveness and Safety of Respiratory Syncytial Virus Vaccine for US Adults Aged 60 Years or Older

JAMA Network Open(2025)10.1001/jamanetworkopen.2025.8322Source: DataRank Database

Effectiveness and Safety of Respiratory Syncytial Virus Vaccine for US Adults Aged 60 Years or Older is a research paper published in JAMA Network Open (2025). On theSindex it has a DataRank of 0. It has been cited 46 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access46 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 37.01)OA: goldTopics (24)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Pauline Terebuh ORCID,David C. Kaelber ORCID,Rong Xu ORCID,Pamela B. Davis ORCID,Sarah E. Fry

Live enrichment

PubMed:40343698 PMC:PMC12065041 OpenAlex:https://openalex.org/W4410217520

NIA NIH HHS

Grant: R01 AG076649

NIA NIH HHS

Grant: T35 AG086098

NCATS NIH HHS

Grant: UL1 TR002548

NCATS NIH HHS

Grant: UM1 TR004528

FWCI

37.01

Citation Percentile

1.0%

Citation Trend

2025

2026

goldLicense: cc-by

journalhttps://jamanetwork.com/journals/jamanetworkopen/articlepdf/2833776/fry_2025_oi_250302_1746203859.61115.pdf

publisherhttps://jamanetwork.com/journals/jamanetworkopen/articlepdf/2833776/fry_2025_oi_250302_1746203859.61115.pdf

journalhttps://doi.org/10.1001/jamanetworkopen.2025.8322

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40343698

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/12065041

Fields of Study

Respiratory viral infections researchCOVID-19 Clinical Research StudiesVirology and Viral Diseases

MeSH Terms

Vaccine EfficacyAgedAged, 80 and overFemaleHospitalizationHumansMaleMiddle AgedUnited StatesCase-Control StudiesRespiratory Syncytial Virus InfectionsRespiratory Syncytial Virus Vaccines

Keywords

MedicineAdverse effectEmergency departmentOdds ratioPediatricsVaccinationInternal medicineEmergency medicineImmunology

Sustainable Development Goals

SDG 0: Good health and well-being